Stuart Hobbs

EFFECTIVE SUPPRESSION OF DIHYDROTESTOSTERONE (DHT) BY GI198745, A NOVEL, DUAL 5 ALPHA REDUCTASE INHIBITOR

D. Hermann, R. V. Clark, Hoda Gabriel, 1999 .

RELATIONSHIP BETWEEN SERUM PSA AND TOTAL PROSTATE AND TRANSITION ZONE VOLUME IN MEN WITH CLINICAL BPH

P. Boyle, C. Roehrborn, R. V. Clark, 1999 .

Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor.

G. Cunningham, D. Hermann, R. V. Clark, 2004, The Journal of clinical endocrinology and metabolism.

The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.

Roger S Rittmaster, David Whiting, R. Rittmaster, 2006, Journal of the American Academy of Dermatology.

About the Special Report.

Scott Gottlieb, Issam Zineh, Marisa Papaluca-Amati, 2018, The Hastings Center report.

Learning from product labels and label changes: how to build pharmacogenomics into drug-development programs.

I. Zineh, L. Lesko, L. Surh, 2010, Pharmacogenomics.